Combined Immunodeficiency

Gene: B2M

Green List (high evidence)

B2M (beta-2-microglobulin)
EnsemblGeneIds (GRCh38): ENSG00000166710
EnsemblGeneIds (GRCh37): ENSG00000166710
OMIM: 109700, Gene2Phenotype
B2M is in 2 panels

1 review

Danielle Ariti (University of Melbourne)

Green List (high evidence)

Two unrelated families and Two mouse models.

PMID: 16549777 (2006). 2 related individuals, homozygous for missense c.913G-C (transversion) in B2M gene; two mouse models. They both presented with Familial hypocalciuric hypercalcemia (FHH), IgG deficiencies (severe FcRn deficiency) and B2M serum levels less than 1.0%.

PMID: 25702838 (2015). 2 related individuals, homozygous for missense c.67+1G-T (transversion) variant (parents were heterozygotes) in B2M gene. One individual presented with recurrent respiratory tract infections and severe skin disease, and the other was reasonably asymptomatic but had bronchiectasis.
Created: 15 Jul 2021, 5:05 a.m. | Last Modified: 15 Jul 2021, 5:05 a.m.
Panel Version: 0.201

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Immunodeficiency 43 MIM# 241600; Sinopulmonary infections; Purple-red skin lesions; - Decreased serum IgG; Decreased B cells; Absent β2m associated proteins MHC-I, CD1a, CD1b, and CD1c

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Melbourne Genomics Health Alliance Immunology Flagship
  • Victorian Clinical Genetics Services
Phenotypes
  • Immunodeficiency 43 MIM# 241600
  • Sinopulmonary infections
  • Purple-red skin lesions
  • Decreased serum IgG
  • Decreased B cells
  • Absent β2m associated proteins MHC-I, CD1a, CD1b, and CD1c
  • MONDO:0009434
OMIM
109700
Clinvar variants
Variants in B2M
Penetrance
None
Publications
Panels with this gene

History Filter Activity

15 Jul 2021, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: B2M were changed from Immunodeficiency 43 MIM# 241600; Sinopulmonary infections; Purple-red skin lesions; - Decreased serum IgG; Decreased B cells; Absent β2m associated proteins MHC-I, CD1a, CD1b, and CD1c; MONDO:0009434 to Immunodeficiency 43 MIM# 241600; Sinopulmonary infections; Purple-red skin lesions; Decreased serum IgG; Decreased B cells; Absent β2m associated proteins MHC-I, CD1a, CD1b, and CD1c; MONDO:0009434

15 Jul 2021, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: b2m has been classified as Green List (High Evidence).

15 Jul 2021, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: B2M were changed from to Immunodeficiency 43 MIM# 241600; Sinopulmonary infections; Purple-red skin lesions; - Decreased serum IgG; Decreased B cells; Absent β2m associated proteins MHC-I, CD1a, CD1b, and CD1c; MONDO:0009434

15 Jul 2021, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: B2M were set to

15 Jul 2021, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of inheritance for gene: B2M was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: B2M was added gene: B2M was added to Combined immunodeficiency_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: B2M was set to Unknown